GSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...

Indian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minist...

Drugs launched over 20 yrs ago remain money-spinners in the Indian pharma mkt because of strong brand recall and better access in smaller c...

Pfizer India, the Indian arm of the US drug major Pfizer Inc, reported muted performance for the four months ended March 2011.

According to an audited retail sales data, all except two of the top 25 brands were launched prior to 2000 and some as early as the seventi...

They are some of the most common drugs consumed in India. But PM’s high-level expert group on universal health coverage claims that they ar...

The drug controller has sought price details of 65 excipients used to make medicines, possibly to revise their prices that was last done in...

Piramal Healthcare’s cough syrup Phensedyl has toppled Swiss drug major Novartis’s pain killer brand Voveran to emerge as the country’s lar...

Cipla's sales grew 15.3% from last month, garnering 4.92% while Ranbaxy sales grew just 0.9% with a mkt share of 4.81%. Drug cos in price w...

There is an old saying, "Health is better than wealth" and I think more and more people are making it their mantra.

Indian pharma companies which paid little focus on building brands will soon have to do so.